Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bilikallahalli K Muralidhara

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Drug Discovery Today|January 12, 2020
Critical considerations in the formulation development of parenteral biologic drugsBilikallahalli K Muralidhara, Marcus Wong
Drug Discovery Today|December 18, 2015
Critical considerations for developing nucleic acid macromolecule based drug productsBilikallahalli K Muralidhara, Rinku Baid, Steve M Bishop, et al.
Analytical and Bioanalytical Chemistry|June 29, 2010
Quantitation of plasmid DNA deposited on gold particles for particle-mediated epidermal delivery using ICP-MSColin D Medley, Bilikallahalli K Muralidhara, Steven Chico, et al.
Journal of Separation Science|August 24, 2010
Rapid and refined separation of human IgG2 disulfide isomers using superficially porous particlesQian Wang, Nathan A Lacher, Bilikallahalli K Muralidhara, et al.
Journal of Pharmaceutical Sciences|August 26, 2010
Comparative evaluation of disodium edetate and diethylenetriaminepentaacetic acid as iron chelators to prevent metal-catalyzed destabilization of a therapeutic monoclonal antibodyShuxia Zhou, Bo Zhang, Emily Sturm, et al.
Journal of Pharmaceutical Sciences|March 6, 2017
Feasibility of Freeze-Drying Oil-in-Water Emulsion Adjuvants and Subunit Proteins to Enable Single-Vial Vaccine Drug ProductsVidyashankara Iyer, Corinne Cayatte, Jason D Marshall, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Drug Discovery Today|January 12, 2020
Critical considerations in the formulation development of parenteral biologic drugsBilikallahalli K Muralidhara, Marcus Wong
Drug Discovery Today|December 18, 2015
Critical considerations for developing nucleic acid macromolecule based drug productsBilikallahalli K Muralidhara, Rinku Baid, Steve M Bishop, et al.
Analytical and Bioanalytical Chemistry|June 29, 2010
Quantitation of plasmid DNA deposited on gold particles for particle-mediated epidermal delivery using ICP-MSColin D Medley, Bilikallahalli K Muralidhara, Steven Chico, et al.
Journal of Separation Science|August 24, 2010
Rapid and refined separation of human IgG2 disulfide isomers using superficially porous particlesQian Wang, Nathan A Lacher, Bilikallahalli K Muralidhara, et al.
Journal of Pharmaceutical Sciences|August 26, 2010
Comparative evaluation of disodium edetate and diethylenetriaminepentaacetic acid as iron chelators to prevent metal-catalyzed destabilization of a therapeutic monoclonal antibodyShuxia Zhou, Bo Zhang, Emily Sturm, et al.
Journal of Pharmaceutical Sciences|March 6, 2017
Feasibility of Freeze-Drying Oil-in-Water Emulsion Adjuvants and Subunit Proteins to Enable Single-Vial Vaccine Drug ProductsVidyashankara Iyer, Corinne Cayatte, Jason D Marshall, et al.
Pageof 1